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To the Editor, 
 
UV irradiation is known to trigger and exacerbate cutaneous lupus erythematosus (CLE) in 
genetically susceptible individuals. UV irradiation is capable of inducing, in a delayed 
fashion, even systemic organ manifestations of lupus erythematosus (LE) (Hasan et al. 2004; 
Lehmann and Homey 2009). About half of LE patients have preceding polymorphic light 
eruption several years before the onset of lupus (Nyberg et al. 1997). UV irradiation induces 
keratinocyte apoptosis in CLE skin (Kuhn et al. 2006), and endogenous nucleic acids can 
induce IFN-associated responses in cultured keratinocytes (Scholtissek et al. 2017). However, 
the exact mechanism of how UV irradiation induces CLE is not known. 
 
To understand the early in vivo molecular UV-induced changes in human skin, we performed 
UVB photoprovocation (Supplementary Figure S1 online) on the intact skin of 20 patients 
with CLE (discoid and subacute) and on four healthy volunteers with no history of 
photosensitivity (Supplementary Table S1 online), and analyzed skin biopsies obtained both 
from photoprovocated and from unexposed skin of the same individual. Skin biopsies (three 
per subject, i.e. total 42 samples) from three DLE, seven SCLE and four healthy control 
subjects were analyzed by mRNA sequencing (RNA-Seq; Supplementary Table S1 online). 
The major variation in gene expression was between the photoprovocated skin samples, 
irrespective of the diagnostic group, and the unexposed skin samples (Supplementary Figure 
S2 online). The expression profile of the pre-photoprovocation skin samples and of those kept 
unexposed (biopsied after photoprovocation) were concordant and were thus combined to 
serve as controls for the UV-exposed skin samples. 
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To analyze the in vivo UVB effect on healthy skin, we compared the photoprovocated healthy 
subject samples to the combined control samples from the same individuals, and found 162 
differentially expressed genes (DEGs), which we regarded as photoprovocation-response 
genes of healthy skin (column “Healthy” is “UP” or “DOWN” of Supplementary Table S2 
online). Genes related to nucleic acid binding (Figure 1a) and erythematous reactions (Figure 
1b) represented the majority of the DEGs. A nucleosome subunit and small nuclear 
ribonucleoproteins (snRNPs), known as autoantigens in systemic lupus erythematosus (SLE; 
Figure 1c; H2AFZ, a variant of histone H2A; SNRPB, Sm-B snRNP; SNRPD3, Sm-D 
snRNP), were up-regulated by photoprovocation. Therefore, even in healthy human skin 
UVB response, induction of autoantigens occurred. 
 
In comparisons of the in vivo UVB effect on healthy, DLE and SCLE skin, we found 411 
DEGs in total (Supplementary Table S2 online), of which 13% (54/411) were consistently 
altered in DLE and SCLE (“Altered” in Supplementary Table S2 online), and 19 out of the 54 
were specifically up-regulated genes in DLE and SCLE skin but not in healthy skin; for 
example, a major histocompatibility complex (MHC) II gene HLA-DPA1 (Figure 2a), an 
IFN-induced ubiquitin-like modifier ISG15, a proteasome activator subunit PSME2, an 
ubiquitin-conjugating enzyme UBE2L6, and known IFN-induced protein with 
tetratricopeptide repeat family genes IFIT1, IFIT2 and IFIT3. The altered genes were also up-
regulated in many cell lines by IFN-γ and IFN-α (Figure 2b). Therefore, we conclude that UV 
exposure of DLE and SCLE skin results in enhanced protein degradation and antigen 
presentation, suggested to be brought about by IFNs. 
 
The induction of the IFIT1/2/3 mRNAs by qRT-PCR (quantitative real-time reverse 
transcriptase PCR) was confirmed in a larger set of skin samples (Supplementary Table S1 
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online), and the difference was significant for IFIT1/2 in SCLE (Figure 2c; P < 0.05). The 
IFIT1/2/3 protein expression in the skin lesions was concordant with the mRNA expression 
(Figure 2d and Supplementary Table S3 online). Typically, IFIT1 was mostly expressed in 
basal keratinocytes while IFIT2 and IFIT3 were more evenly distributed in the epidermis. 
IFIT2 is a mediator of apoptosis via a mitochondrial pathway (Stawowczyk et al. 2011), and 
photoprovocation induced consistently apoptotic keratinocytes in all but one individual, 
typically more strongly in 60% of the SCLE samples (Supplementary Figure S3 and Table S3 
online). Since IFIT2 can bind to AU-rich element (Yang et al. 2012), which can be found 
around the 3’-end of mammalian mRNAs (Chen and Shyu 1995), and is involved in post-
transcriptional regulation (Berchtold et al. 2008), IFIT2 might increase the amount of 
fragmented endogenous RNAs, which induce IFN responses in keratinocytes (Scholtissek et 
al. 2017), sustaining the skin lesion. 
 
We also measured serum IFN-α values before and after photoprovocation (Supplementary 
Figure S1a online) with Simoa and serum IFN-γ values with Luminex. No significant 
increase in serum IFN levels was found during photoprovocation of small skin areas. 
However, when combining the serology results with the IFIT gene expression data, the 
majority (8/10) of the SCLE patients showed strong up-regulation of the IFIT genes and 
serum IFN-α levels up to 0.62 pg/ml, while only one third of the DLE patients showed up-
regulation of the IFIT genes and measurable IFN-α or IFN-γ in their serum, even prior to 
photoprovocation (Supplementary Table S3 online). Typically, SCLE is the most UV-
sensitive subtype of LE, and SCLE patients frequently fulfil four or more of the SLE criteria. 
No remarkable serum levels of any other cytokines measured were found except for one DLE 
case who had elevated IL-17A (103 pg/ml) and the highest IFN-γ levels.  
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In summary, our findings delineate the healthy human skin UV response genes, including 
induction of autoantigens, and show that UV irradiation upregulates in particular the IFIT 
family genes of the hundreds of IFN-stimulated genes and the MCH II gene HLA-DPA1 in 
CLE skin but not in healthy skin. Our findings revisit the importance of UV avoidance and 
the constitutive IFN production in autoimmune disorders (Funabiki et al. 2014), and 
emphasize early targeting of the IFN pathway also in cutaneous lupus, with for example 
monoclonal anti-IFN antibodies already in clinical trials for SLE (Kalunian 2016; Merrill et 
al. 2011).  
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FIGURE LEGENDS 
 
Figure 1. Inspection of normal UV photoprovocation-response genes. 
(a) Classification of the up-regulated (top) and down-regulated (bottom) genes by 
photoprovocation based on PANTHER protein classes.  
(b) Ten first Human Phenotype Ontology terms, in which the up-regulated genes by 
photoprovocation were enriched significantly. Numbers on each bar represent the number of 
member genes of the term (at the denominator), and the number of the response genes among 
the member (at the numerator). The specific response genes are checked in the matrix. 
(c) Healthy skin UV photoprovocation-response genes indicated in the known SLE pathway 
[KEGG: hsa05322]. Rectangle boxes indicate molecules in this pathway. White box genes do 
not exist in human. Yellow box genes were up-regulated by photoprovocation in control skin 
samples. 
 
Figure 2. Altered UV-photoprovocation-response genes in DLE and SCLE. 
(a) The up-regulated genes (yellow box) in the known SLE pathway [KEGG: hsa05322].  
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(b) Ten most enriched gene sets in the LINCS L1000 ligand perturbation dataset, and the 
altered genes corresponding to the enriched gene sets; each gene set consists of differentially 
regulated genes induced by a ligand in a cell-line. 
(c) Up-regulation of IFIT1/2/3 mRNA expression in photoprovocated SCLE (in all but two) 
and DLE skin lesions, by qRT-PCR validation.  
(d) IFIT protein expression in skin samples by immunohistochemistry. IFIT proteins are more 
strongly expressed in SCLE than healthy control after UV-provocation. Note the strong 
expression (dark brown color) especially in basal keratinocytes and in areas with apoptotic 
keratinocytes (i.e. cells with pyknotic nuclei and eosinophilic cytoplasm). Scale bar = 100 
µm. 
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